{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:56:42Z","timestamp":1794491802566,"version":"4.9.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900344"],"award-info":[{"award-number":["81900344"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2022JJ30884"],"award-info":[{"award-number":["2022JJ30884"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Increased acid sphingomyelinase (ASMase) activity is associated with insulin resistance and cardiac dysfunction. However, the effects of ASMase on diabetic cardiomyopathy (DCM) and the molecular mechanism(s) underlying remain to be elucidated. We here investigated whether ASMase caused DCM through NADPH oxidase 4-mediated apoptosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>\n                      We used pharmacological and genetic approaches coupled with study of murine and cell line samples to reveal the mechanisms initiated by ASMase in diabetic hearts. The protein expression and activity of ASMase were upregulated, meanwhile ceramide accumulation was increased in the myocardium of HFD mice. Inhibition of ASMase with imipramine (20\u00a0mg\u00a0Kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      \u00a0d\n                      <jats:sup>\u22121<\/jats:sup>\n                      ) or siRNA reduced cardiomyocyte apoptosis, fibrosis, and mitigated cardiac hypertrophy and cardiac dysfunction in HFD mice. The similar effects were observed in cardiomyocytes treated with high glucose (HG, 30\u00a0mmol\u00a0L\n                      <jats:sup>\u22121<\/jats:sup>\n                      )\u2009+\u2009palmitic acid (PA, 100\u00a0\u03bcmol\u00a0L\n                      <jats:sup>\u22121<\/jats:sup>\n                      ) or C16 ceramide (CER, 20\u00a0\u03bcmol\u00a0L\n                      <jats:sup>\u22121<\/jats:sup>\n                      ). Interestingly, the cardioprotective effect of ASMase inhibition was not accompanied by reduced ceramide accumulation, indicating a ceramide-independent manner. The mechanism may involve activated NADPH oxidase 4 (NOX4), increased ROS generation and triggered apoptosis. Suppression of NOX4 with apocynin prevented HG\u2009+\u2009PA and CER incubation induced\n                      <jats:italic>Nppb<\/jats:italic>\n                      and\n                      <jats:italic>Myh7<\/jats:italic>\n                      pro-hypertrophic gene expression, ROS production and apoptosis in H9c2 cells. Furthermore, cardiomyocyte-specific ASMase knockout (ASMase\n                      <jats:sup>Myh6KO<\/jats:sup>\n                      ) restored HFD-induced cardiac dysfunction, remodeling, and apoptosis, whereas NOX4 protein expression was downregulated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results demonstrated that HFD-mediated activation of cardiomyocyte ASMase could increase NOX4 expression, which may stimulate oxidative stress, apoptosis, and then cause metabolic cardiomyopathy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-023-01747-1","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T11:30:36Z","timestamp":1675337436000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Acid sphingomyelinase promotes diabetic cardiomyopathy via NADPH oxidase 4 mediated apoptosis"],"prefix":"10.1186","volume":"22","author":[{"given":"Ruijiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"key":"1747_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.hfc.2019.02.003","volume":"15","author":"S Paolillo","year":"2019","unstructured":"Paolillo S, Marsico F, Prastaro M, Renga F, Esposito L, Martino FD, et al. Diabetic cardiomyopathy definition, diagnosis, and therapeutic implications. Heart Fail Clin. 2019;15:341\u20137.","journal-title":"Heart Fail Clin"},{"key":"1747_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.amjmed.2019.08.035","volume":"133","author":"E Koutroumpakis","year":"2020","unstructured":"Koutroumpakis E, Jozwik B, Aguilar D, Taegtmeyer H. Strategies of unloading the failing heart from metabolic stress. Am J Med. 2020;133:290\u20136.","journal-title":"Am J Med"},{"key":"1747_CR3","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1161\/CIRCRESAHA.120.317943","volume":"129","author":"S Oka","year":"2021","unstructured":"Oka S, Byun J, Huang C, Imai N, Ralda G, Zhai P, et al. Nampt potentiates antioxidant defense in diabetic cardiomyopathy. Circ Res. 2021;129:114\u201330.","journal-title":"Circ Res"},{"key":"1747_CR4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1182\/blood.2019001400","volume":"134","author":"J Wang","year":"2019","unstructured":"Wang J, Pendurthi UR, Rao LVM. Acid sphingomyelinase plays a critical role in LPS-and cytokine-induced tissue factor procoagulant activity. Blood. 2019;134:645\u201355.","journal-title":"Blood"},{"key":"1747_CR5","doi-asserted-by":"publisher","first-page":"23978","DOI":"10.1074\/jbc.M116.737684","volume":"291","author":"M Park","year":"2016","unstructured":"Park M, Kaddai V, Ching J, Fridianto KT, Sieli RJ, Sugii S, et al. A role for ceramides, but not sphingomyelins, as antagonists of insulin signaling and mitochondrial metabolism in C2C12 myotubes*. J Biol Chem. 2016;291:23978\u201388.","journal-title":"J Biol Chem"},{"key":"1747_CR6","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1161\/ATVBAHA.116.307497","volume":"36","author":"AS Havulinna","year":"2018","unstructured":"Havulinna AS, Sysi-Aho M, Hilvo M, Kauhanen D, Hurme R, Ekroos K, et al. Circulating ceramides predict cardiovascular outcomes in the population-based FINRISK 2002 cohort. Arterioscler Thromb Vasc Biol. 2018;36:2424\u201330.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1747_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1093\/eurheartj\/ehl541","volume":"28","author":"W Doehner","year":"2007","unstructured":"Doehner W, Bunck AC, Rauchhaus M, von Haehling S, Brunkhorst FM, Cicoira M, et al. Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow. Eur Heart J. 2007;28:821\u20138.","journal-title":"Eur Heart J"},{"key":"1747_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1749-8090-6-38","volume":"6","author":"E Usta","year":"2011","unstructured":"Usta E, Mustafi M, Artunc F, Walker T, Voth V, Aebert H, et al. The challenge to verify ceramide\u2019s role of apoptosis induction in human cardiomyocytes\u2014a pilot study. J Cardiothorac Surg. 2011;6:38.","journal-title":"J Cardiothorac Surg"},{"key":"1747_CR9","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3390\/ijms18040839","volume":"18","author":"H-Y Chung","year":"2017","unstructured":"Chung H-Y, Kollmey AS, Schrepper A, Kohl M, Bl\u00e4ss MF, Stehr SN, et al. Adjustment of dysregulated ceramide metabolism in a murine model of sepsis-induced cardiac dysfunction. Int J Mol Sci. 2017;18:839.","journal-title":"Int J Mol Sci"},{"key":"1747_CR10","doi-asserted-by":"publisher","first-page":"8359","DOI":"10.1074\/jbc.M807800200","volume":"284","author":"GM Deevska","year":"2009","unstructured":"Deevska GM, Rozenova KA, Giltiay NV, Chambers MA, White J, Boyanovsky BB, et al. Acid sphingomyelinase deficiency prevents diet-induced hepatic triacylglycerol accumulation and hyperglycemia in mice*. J Biol Chem. 2009;284:8359\u201368.","journal-title":"J Biol Chem"},{"key":"1747_CR11","doi-asserted-by":"publisher","first-page":"e146343","DOI":"10.1172\/JCI146343","volume":"132","author":"PD Pietro","year":"2022","unstructured":"Pietro PD, Carrizzo A, Sommella E, Oliveti M, Iacoviello L, Castelnuovo AD, et al. Targeting the ASMase\/S1P pathway protects from sortilin-evoked vascular damage in hypertension. J Clin Invest. 2022;132:e146343.","journal-title":"J Clin Invest"},{"key":"1747_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12933-022-01596-4","volume":"21","author":"PN Jensen","year":"2022","unstructured":"Jensen PN, Fretts AM, Hoofnagle AN, McKnight B, Howard BV, Umans JG, et al. Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study. Cardiovasc Diabetol. 2022;21:167.","journal-title":"Cardiovasc Diabetol"},{"key":"1747_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1126\/science.1173278","volume":"324","author":"CM Crowder","year":"2009","unstructured":"Crowder CM. Ceramides-friend or foe in hypoxia? Science. 2009;324:343\u20134.","journal-title":"Science"},{"key":"1747_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jacl.2020.01.005","volume":"14","author":"A Mantovani","year":"2020","unstructured":"Mantovani A, Dugo C. Ceramides and risk of major adverse cardiovascular events: a meta-analysis of longitudinal studies. J Clin Lipidol. 2020;14:176\u201385.","journal-title":"J Clin Lipidol"},{"key":"1747_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1126\/science.1158111","volume":"322","author":"X Deng","year":"2008","unstructured":"Deng X, Yin X, Allan R, Lu DD, Maurer CW, Haimovitz-Friedman A, et al. Ceramide biogenesis is required for radiation-induced apoptosis in the germ line of C. elegans. Science. 2008;322:110\u20135.","journal-title":"Science"},{"key":"1747_CR16","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/acer.14822","volume":"46","author":"C Wang","year":"2022","unstructured":"Wang C, Li S, Liu Q, Qian Q, Fu A, Chen L, et al. Ectopic accumulation of ceramide in cardiomyocytes modulates alcoholic cardiomyopathy via the TLR4-dependent pathway. Alcohol Clin Exp Res. 2022;46:1011\u201322.","journal-title":"Alcohol Clin Exp Res"},{"key":"1747_CR17","doi-asserted-by":"publisher","first-page":"18429","DOI":"10.1074\/jbc.M111.296947","volume":"287","author":"S-Y Lee","year":"2012","unstructured":"Lee S-Y, Kim JR, Hu Y, Khan R, Kim S-J, Bharadwaj KG, et al. Cardiomyocyte specific deficiency of serine palmitoyltransferase subunit 2 reduces ceramide but leads to cardiac dysfunction*. J Biol Chem. 2012;287:18429\u201339.","journal-title":"J Biol Chem"},{"key":"1747_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-022-07378-0","author":"Y Ji","year":"2022","unstructured":"Ji Y, Chen J, Pang L, Chen C, Ye J, Liu H, et al. The acid sphingomyelinase inhibitor amitriptyline ameliorates TNF-\u03b1-induced endothelial dysfunction. Cardiovasc Drug Ther. 2022.","journal-title":"Cardiovasc Drug Ther"},{"key":"1747_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.yjmcc.2016.02.019","volume":"93","author":"M Klevstig","year":"2016","unstructured":"Klevstig M, St\u00e5hlman M, Lundqvist A, T\u00e4ng MS, Fogelstrand P, Adiels M, et al. Targeting acid sphingomyelinase reduces cardiac ceramide accumulation in the post-ischemic heart. J Mol Cell Cardiol. 2016;93:69\u201372.","journal-title":"J Mol Cell Cardiol"},{"key":"1747_CR20","first-page":"E131","volume":"318","author":"Z Lu","year":"2020","unstructured":"Lu Z, Li Y, Syn W-K, Wang Z, Lopes-Virella MF, Lyons TJ, et al. Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of sphingolipid metabolism. Am J Physiol-Endoc M. 2020;318:E131\u201344.","journal-title":"Am J Physiol-Endoc M"},{"key":"1747_CR21","doi-asserted-by":"publisher","first-page":"e14618","DOI":"10.15252\/emmm.202114618","volume":"13","author":"C Muley","year":"2021","unstructured":"Muley C, Bartelt A. Fuse your mitochondria, lose appetite: an anorexic, anti-obesity sphingolipid. Embo Mol Med. 2021;13:e14618.","journal-title":"Embo Mol Med"},{"key":"1747_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.freeradbiomed.2021.02.016","volume":"167","author":"M Bekhite","year":"2021","unstructured":"Bekhite M, Gonz\u00e1lez-Delgado A, H\u00fcbner S, Haxhikadrija P, Kretzschmar T, M\u00fcller T, et al. The role of ceramide accumulation in human induced pluripotent stem cell-derived cardiomyocytes on mitochondrial oxidative stress and mitophagy. Free Radical Bio Med. 2021;167:66\u201380.","journal-title":"Free Radical Bio Med"},{"key":"1747_CR23","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41467-017-00664-8","volume":"8","author":"W Liu","year":"2017","unstructured":"Liu W, Ruiz-Velasco A, Wang S, Khan S, Zi M, Jungmann A, et al. Metabolic stress-induced cardiomyopathy is caused by mitochondrial dysfunction due to attenuated Erk5 signaling. Nat Commun. 2017;8:494.","journal-title":"Nat Commun"},{"key":"1747_CR24","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1038\/s41401-020-0475-6","volume":"41","author":"Z Chen","year":"2020","unstructured":"Chen Z, Sun X, Li X, Xu Z, Yang Y, Lin Z, et al. Polydatin attenuates renal fibrosis in diabetic mice through regulating the Cx32-Nox4 signaling pathway. Acta Pharmacol Sin. 2020;41:1587\u201396.","journal-title":"Acta Pharmacol Sin"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01747-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-01747-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01747-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T11:34:04Z","timestamp":1675337644000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-01747-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1747"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-01747-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2324589\/v1","asserted-by":"object"}]},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]},"assertion":[{"value":"29 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed according to the Guidelines of Animal Experiments from Committee of Medical Ethics at the National Health Department of China and were approved by Central South University (NO: 2019-S131).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}